Video
Kyle Truitt, Co-Founder, Turning Point, LLC, speaks about how pharmaceutical manufacturers can benefit from the launch of the High-Performing Specialty Pharmacy Association.
Truitt: These pharmacies produce top level outcomes, great results in persistence and compliance, and they also invest heavily in information technology to facilitate care and to coordinate reporting. So the concept is to work together to leverage purchasing, reporting, access to limited distribution drugs, and programs around that, and to provide payers with access to a large, high quality, specialty pharmacy network with broad access to drugs.
FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a